Not a good buy right now: price is breaking down on the day (-5.77% regular session; -4.01% pre-market) and momentum is still bearish.
Even though sentiment (options + analysts) is constructive, the chart is not showing a confirmed reversal; odds favor more chop/down before a cleaner entry.
Best stance today for an impatient trader: hold off on new buys until price reclaims the ~$9.85 area (former support) or flushes toward ~$8.86 and stabilizes.
Trend/momentum: MACD histogram is negative (-0.34) and expanding lower, signaling bearish momentum is strengthening.
RSI: RSI(6) at ~27.5 suggests the stock is short-term oversold, but oversold alone is not a buy trigger without confirmation.
Key levels: Current price ~$9.655 is below S1 ~9.852 (lost support). Next notable support is S2 ~8.863; upside reclaim level is back above ~9.85, then pivot ~11.45.
Moving averages: MAs are converging (no clear uptrend support), consistent with a transition phase rather than a clean bullish trend.
Pattern-based forward odds (provided): modest edge only (next day ~50% chance to +0.52%; next week +0.13%; next month +2.75%)—not strong enough to override the bearish tape today.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Put/Call ratios are very low (OI PCR 0.21; Volume PCR 0.33), indicating bullish-to-risk-on positioning.
Activity: Today’s option volume (2,335) is elevated vs typical levels (today vs 30D avg volume ~35.91), suggesting heightened event-driven interest.
Volatility: IV is extremely elevated (30D IV ~84.5; IV percentile ~95.22) versus HV ~81.37—options are pricing large moves; this often aligns with event/merger/earnings uncertainty.
Skew implication: Heavy call OI (calls 102,201 vs puts 21,159) supports a bullish bias, but with IV this high, the market is also pricing meaningful two-way risk.
Technical Summary
Sell
4
Buy
8
Positive Catalysts
on 2026-02-18 after hours with EPS estimate ~0.27, which can reset expectations if strong.
Neutral/Negative Catalysts
with bearish MACD reduces probability of an immediate sustained bounce.
Congress/politician activity: No recent congress trading data available (no signal from influential political trading).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
2026-01-26 (Scotiabank): Raised PT to $12.75 from $10.50; reiterated Outperform; constructive macro view for gold/silver supports the group.
2026-01-23 (Canaccord): Raised PT to C$18 from C$15; reiterated Buy.
Wall Street pros: Upward PT revisions suggest improving confidence and a bullish medium-term view.
Wall Street cons: Despite bullish ratings, the stock’s near-term tape is weak today and the market is pricing elevated uncertainty (high IV), so timing is unfavorable for an immediate buy.
Wall Street analysts forecast NGD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NGD is 9.37 USD with a low forecast of 8 USD and a high forecast of 12 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast NGD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NGD is 9.37 USD with a low forecast of 8 USD and a high forecast of 12 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 9.430
Low
8
Averages
9.37
High
12
Current: 9.430
Low
8
Averages
9.37
High
12
Scotiabank
Eric Winmill
Outperform
maintain
AI Analysis
2026-01-26
Reason
Scotiabank
Eric Winmill
Price Target
AI Analysis
2026-01-26
maintain
Outperform
Reason
Scotiabank analyst Eric Winmill raised the firm's price target on New Gold to $12.75 from $10.50 and keeps an Outperform rating on the shares. The firm is updating its price targets for Gold & Precious Minerals stocks under its coverage, the analyst tells investors. The firm has increased both gold and silver forecasts, supported by economic and geopolitical uncertainty as well as strong central bank buying.
Canaccord
NULL -> Buy
maintain
$15 -> $18
2026-01-23
Reason
Canaccord
Price Target
$15 -> $18
2026-01-23
maintain
NULL -> Buy
Reason
Canaccord raised the firm's price target on New Gold to C$18 from C$15 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NGD